These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11071087)
41. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Vajo Z; Francomano CA; Wilkin DJ Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568 [TBL] [Abstract][Full Text] [Related]
42. Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia. Deutz-Terlouw PP; Losekoot M; Aalfs CM; Hennekam RC; Bakker E Hum Mutat; 1998; Suppl 1():S62-5. PubMed ID: 9452043 [No Abstract] [Full Text] [Related]
43. Identification of a novel mutation of FGFR3 gene in a large Chinese pedigree with hypochondroplasia by next-generation sequencing: A case report and brief literature review. Yao G; Wang G; Wang D; Su G Medicine (Baltimore); 2019 Jan; 98(4):e14157. PubMed ID: 30681580 [TBL] [Abstract][Full Text] [Related]
44. Achondroplasia with the FGFR3 1138g-->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father. Sobetzko D; Braga S; Rüdeberg A; Superti-Furga A J Med Genet; 2000 Dec; 37(12):958-9. PubMed ID: 11186940 [No Abstract] [Full Text] [Related]
45. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level. Cohen MM Int J Oral Maxillofac Surg; 1998 Dec; 27(6):451-5. PubMed ID: 9869286 [TBL] [Abstract][Full Text] [Related]
46. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family. Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403 [TBL] [Abstract][Full Text] [Related]
47. Comparison of clinical, radiological and molecular findings in Korean infants and children with achondroplasia and hypochondroplasia. Shin YL; Choi JH; Kim GH; Yoo HW J Pediatr Endocrinol Metab; 2005 Oct; 18(10):999-1005. PubMed ID: 16355813 [TBL] [Abstract][Full Text] [Related]
48. Rapid combined genotyping assay for four achondroplasia and hypochondroplasia mutations by real-time PCR with multiple detection probes. Schrijver I; Lay MJ; Zehnder JL Genet Test; 2004; 8(2):185-9. PubMed ID: 15345118 [TBL] [Abstract][Full Text] [Related]
49. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Heuertz S; Le Merrer M; Zabel B; Wright M; Legeai-Mallet L; Cormier-Daire V; Gibbs L; Bonaventure J Eur J Hum Genet; 2006 Dec; 14(12):1240-7. PubMed ID: 16912704 [TBL] [Abstract][Full Text] [Related]
50. A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia. Winterpacht A; Hilbert K; Stelzer C; Schweikardt T; Decker H; Segerer H; Spranger J; Zabel B Physiol Genomics; 2000 Jan; 2(1):9-12. PubMed ID: 11015576 [TBL] [Abstract][Full Text] [Related]
51. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A Horm Res; 1996; 45(1-2):108-10. PubMed ID: 8742128 [TBL] [Abstract][Full Text] [Related]
52. Clinical hypochondroplasia in a family caused by a heterozygous double mutation in FGFR3 encoding GLY380LYS. Santos HG; Almeida M; Fernandes H; Wilkie AO Am J Med Genet A; 2007 Feb; 143(4):355-9. PubMed ID: 17256796 [TBL] [Abstract][Full Text] [Related]
53. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Iwata T; Li CL; Deng CX; Francomano CA Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607 [TBL] [Abstract][Full Text] [Related]
54. [Molecular basis of achondroplasia, hypochondroplasia, and thanatophoric dysplasia]. Moskalewski S; Hyc A; Osiecka-Iwan A; Strzelczyk P Chir Narzadow Ruchu Ortop Pol; 2000; 65(3):327-33. PubMed ID: 11057021 [TBL] [Abstract][Full Text] [Related]
55. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586 [TBL] [Abstract][Full Text] [Related]
57. Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare Ekinci S; Ülger Y; Acar MO; Ceran A; Aycan Z; Fitoz ÖS; Ilgın Ruhi H J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1097-1101. PubMed ID: 35438268 [TBL] [Abstract][Full Text] [Related]
58. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. Webster MK; Donoghue DJ EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935 [TBL] [Abstract][Full Text] [Related]
59. Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene. Bellus GA; McIntosh I; Szabo J; Aylsworth A; Kaitila I; Francomano CA Ann N Y Acad Sci; 1996 Jun; 785():182-7. PubMed ID: 8702125 [No Abstract] [Full Text] [Related]
60. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Wilkin DJ; Szabo JK; Cameron R; Henderson S; Bellus GA; Mack ML; Kaitila I; Loughlin J; Munnich A; Sykes B; Bonaventure J; Francomano CA Am J Hum Genet; 1998 Sep; 63(3):711-6. PubMed ID: 9718331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]